Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Short term Debt (2016 - 2025)

Historic Short term Debt for Angiodynamics (ANGO) over the last 16 years, with Q1 2025 value amounting to $5.0 million.

  • Angiodynamics' Short term Debt fell 4736.84% to $5.0 million in Q1 2025 from the same period last year, while for Feb 2025 it was $5.0 million, marking a year-over-year decrease of 4736.84%. This contributed to the annual value of $4.7 million for FY2024, which is 6796.96% down from last year.
  • As of Q1 2025, Angiodynamics' Short term Debt stood at $5.0 million, which was down 4736.84% from $5.0 million recorded in Q4 2024.
  • Angiodynamics' 5-year Short term Debt high stood at $14.8 million for Q2 2023, and its period low was $4.7 million during Q2 2024.
  • Moreover, its 4-year median value for Short term Debt was $8.8 million (2022), whereas its average is $7.9 million.
  • Its Short term Debt has fluctuated over the past 5 years, first soared by 6806.33% in 2023, then plummeted by 6796.96% in 2024.
  • Over the past 4 years, Angiodynamics' Short term Debt (Quarter) stood at $9.8 million in 2022, then decreased by 3.82% to $9.4 million in 2023, then crashed by 47.16% to $5.0 million in 2024, then rose by 0.81% to $5.0 million in 2025.
  • Its Short term Debt was $5.0 million in Q1 2025, compared to $5.0 million in Q4 2024 and $4.8 million in Q3 2024.